Zavation releases In-Vitro and In-Vivo Research Summary for its novel “LABYRINTH™”

JACKSON, Miss., Aug. 10, 2022 /PRNewswire/ — Zavation Medical Products (“Zavation” or the “Company”), an innovative designer and manufacturer of spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, MS, announced the results of its novel LABYRINTH™ technology in an In-Vitro and In-Vivo research project. Please click the link below for Zavation’s LABYRINTH™ In-Vitro and In-Vivo…

Read More

LABYRINTH™ Research Study

Labyrinth™ In-Vitro and In-Vivo Research Study      

Read More

Zavation Medical Products, LLC, receives FDA 510K Clearance for eZspand™ Lateral Cage as an addition to its eZspand™ Interbody System.

FLOWOOD, Miss., June 10, 2022 /PRNewswire/ — Zavation Medical Products (“Zavation” or the “Company”), an innovative designer and manufacturer of high-quality spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, MS, announced the FDA 510K Clearance of eZspand™ Lateral, an expandable lumbar interbody fusion device. eZspand™ Lateral Cage Zavation Medical Products, LLC, receives…

Read More

Gemspring Acquires Zavation Medical Products

WESTPORT, Conn., July 7, 2021 /PRNewswire/ — Gemspring Capital Management LLC (“Gemspring”), a middle-market private equity firm, is pleased to announce that an affiliate has acquired a majority interest in Zavation Medical Products, LLC (“Zavation” or the “Company”). Zavation designs and manufactures a comprehensive portfolio of spinal hardware and biologics that provide medical solutions to improve and…

Read More